コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 uate nucleus (ARC) to maintain low levels of serum prolactin.
2 nships between changes in CSF monoamines and serum prolactin and clinical outcome were examined, and
5 and spike duration of TIDA cells, increased serum prolactin can promote dopamine release to limit it
6 s were assessed by measuring the increase in serum prolactin concentration during 5 hours following s
7 osa, the fenfluramine-stimulated increase in serum prolactin concentration was significantly less tha
8 verse events, extrapyramidal symptom scores, serum prolactin concentration, body weight, and metaboli
10 SLE patients display hyperprolactinemia, and serum prolactin correlates with disease activity in some
12 nd cyclosporine are reported to increase the serum prolactin level, producing gynecomastia in men.
18 at persistent mild-to-moderate elevations in serum prolactin levels induce a break in self tolerance
20 ential effects of sustained "high" and "low" serum prolactin levels on bone mineral density and perip
23 rolactin levels and a decrease in endogenous serum prolactin levels, indicating that ovine prolactin
24 e alpha-2 receptor subtype within the PVN on serum prolactin levels; however, the functional signific
25 significantly higher maximum mean levels of serum prolactin (men, 34.56 microg/L [95% CI, 29.75-39.3
27 pment was analyzed by selectively increasing serum prolactin (PRL) concentration in thymus-grafted co
31 d 3-methoxy-4-hydroxyphenylglycol (MHPG) and serum prolactin were measured during drug-free and antip
32 th more weight gain and greater increases in serum prolactin, whereas haloperidol decanoate was assoc
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。